AT270881B - Verfahren zur Herstellung von neuen Adenosinderivaten - Google Patents

Verfahren zur Herstellung von neuen Adenosinderivaten

Info

Publication number
AT270881B
AT270881B AT422767A AT422767A AT270881B AT 270881 B AT270881 B AT 270881B AT 422767 A AT422767 A AT 422767A AT 422767 A AT422767 A AT 422767A AT 270881 B AT270881 B AT 270881B
Authority
AT
Austria
Prior art keywords
preparation
adenosine derivatives
new adenosine
new
derivatives
Prior art date
Application number
AT422767A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of AT270881B publication Critical patent/AT270881B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
AT422767A 1966-05-07 1967-05-05 Verfahren zur Herstellung von neuen Adenosinderivaten AT270881B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0087038 1966-05-07

Publications (1)

Publication Number Publication Date
AT270881B true AT270881B (de) 1969-05-12

Family

ID=6983636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT422767A AT270881B (de) 1966-05-07 1967-05-05 Verfahren zur Herstellung von neuen Adenosinderivaten

Country Status (8)

Country Link
US (1) US3502649A (de)
AT (1) AT270881B (de)
CH (1) CH487926A (de)
FI (1) FI48086C (de)
FR (1) FR6585M (de)
GB (1) GB1123245A (de)
NL (2) NL6706368A (de)
SE (1) SE316774B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2059922A1 (de) * 1970-12-05 1972-06-15 Boehringer Mannheim Gmbh Neue N(6)-Aralkyl-adenosin-Derivate und Verfahren zur Herstellung derselben
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
CA1239397A (en) * 1983-08-01 1988-07-19 James A. Bristol N.sup.6-substituted adenosines
EP0305643B1 (de) * 1984-04-18 1994-01-05 Whitby Research Incorporated N-6-thienyl-substituierte Adenosinderivate als herzgefässerweiternde Mittel
US5310731A (en) 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5030624A (en) * 1988-10-26 1991-07-09 G. D. Searle & Co. R-diastereomer of an N6 -[(2-hydroxypropyl)aryl]adenosine and its medicinal uses
US5032584A (en) * 1988-10-26 1991-07-16 G. D. Searle & Co. S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses
US4992535A (en) * 1988-10-26 1991-02-12 G. D. Searle & Co. Methods of making novel R and S diastereomers of N6 -[(2-hydroxypropyl)aryl]adenosines
ZA902280B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor agents
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5391739A (en) * 1989-03-29 1995-02-21 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
DK0550631T3 (da) * 1990-09-25 1997-01-20 Rhone Poulenc Rorer Int Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi
DK62692D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
DK62592D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
WO2004100964A1 (en) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
US10174033B2 (en) * 2009-12-10 2019-01-08 Institute Of Materia Medica, Chinese Academy Of Medical Sciences N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881164A (en) * 1955-07-18 1959-04-07 American Cyanamid Co Ribofuranosyl derivatives of 6-aralkylamino and 6-heterocyclicalkylaminopurines
US3014900A (en) * 1959-01-26 1961-12-26 Upjohn Co Process for the preparation of ketosidopurines

Also Published As

Publication number Publication date
NL128629C (de)
FI48086C (fi) 1974-06-10
US3502649A (en) 1970-03-24
SE316774B (de) 1969-11-03
GB1123245A (en) 1968-08-14
NL6706368A (de) 1967-11-08
FR6585M (de) 1968-12-30
CH487926A (de) 1970-03-31
FI48086B (de) 1974-02-28

Similar Documents

Publication Publication Date Title
AT294853B (de) Verfahren zur Herstellung von neuen Polysaccharidderivaten
CH492676A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanol-Derivaten
CH489464A (de) Verfahren zur Herstellung von neuen Amino-dihalogen-phenyläthylaminen
AT270881B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
AT272529B (de) Verfahren zur Herstellung von neuen Adenosin-Derivaten
AT289113B (de) Verfahren zur Herstellung von neuen Pyridinderivaten
CH491119A (de) Verfahren zur Herstellung von N6-Aralkyl-adenosin-derivaten
CH489517A (de) Verfahren zur Herstellung von N-Acylsydnoniminderivaten
CH484049A (de) Verfahren zur Herstellung von neuen Hydroxycyclohexylaminen
AT272343B (de) Verfahren zur Herstellung von neuen 2-Cycloalkylamino-oxazolinen
AT291245B (de) Verfahren zur Herstellung von neuen 4-Hydroxycumarinderivaten
CH518255A (de) Verfahren zur Herstellung von Diarylcyclopropan-Derivaten
CH487887A (de) Verfahren zur Herstellung von neuen 1-Aryl-3-alkylaminopyrrolidinen
AT272369B (de) Verfahren zur Herstellung von neuen 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH496663A (de) Verfahren zur Herstellung von 2-Benzyliden-cyclopentanonderivaten
CH482727A (de) Verfahren zur Herstellung von neuen Phosphinylimiden
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
AT289837B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
CH473145A (de) Verfahren zur Herstellung von Adenosin-derivaten
AT277186B (de) Verfahren zur Herstellung von neuen Trihalogenäthylglycinaten
CH487114A (de) Verfahren zur Herstellung von neuen 1-Amino-3-aryloxypropan-2-äthern
AT266141B (de) Verfahren zur Herstellung von neuen Haxahydropyrimidinderivaten
CH509972A (de) Verfahren zur Herstellung von neuen Diisoeugenol-Derivaten
AT272370B (de) Verfahren zur Herstellung von neuen Theophyllinderivaten
CH507256A (de) Verfahren zur Herstellung von Polyuracilderivaten